X avier Rubiralta is a Spanish billionaire and a key shareholder in Werfen, a global leader in specialized diagnostics and medical devices. He inherited his stake in the company from his father, Josep Maria Rubiralta, who founded the business in 1966 in Barcelona. Xavier has served on the board of directors since 2013, helping to guide the family-owned company's strategic direction.
Werfen specializes in critical areas such as hemostasis, acute care diagnostics, and autoimmunity. Under the stewardship of Xavier and his brothers—Jordi, Jose Luis, and Marc—the company has expanded internationally through organic growth and acquisitions, including the purchase of U.S.-based Instrumentation Laboratory. The Rubiralta family remains one of the wealthiest in Catalonia, maintaining private control over their healthcare empire.
Advertisement
Xavier Rubiralta is a Spanish businessman whose fortune stems from Spain-based diagnostics company Werfen. Werfen specializes in medical areas such as hemostasis, acute care, transfusion, autoimmunity and transplants.
Werfen's roots stem from his father and uncle who founded the business in 1966 as a health products distributor. Xavier inherited his stake in the company from his late father in 2012.
Xavier Rubiralta's career is defined by his role in the governance and stewardship of the family enterprise. He inherited his stake in 2012 and has been a member of Werfen's board since 2013.
The company expanded significantly over the years, notably acquiring U.S.-based Instrumentation Laboratory in 1991. The family maintains control through the ownership structure: his brothers Jordi, Jose Luis and Marc also inherited equal stakes from his father and are also billionaires.
Advertisement
Werfen was founded by his father and uncle.
Acquired U.S.-based Instrumentation Laboratory.
Inherited his stake from his late father.
Became a member of Werfen's board.
Xavier Rubiralta's wealth is concentrated in his family's substantial ownership stake in the private healthcare giant, Werfen.
Advertisement
Advertisement
No publicly available quotes.
Advertisement
+0.26% | +$18.84M
+0.01% | +$0.76M
This profile is compiled from verified biographical and financial records:
All information is cross-referenced with public sources for accuracy; some narrative sections are AI-assisted summaries.
If you find any inaccuracies, please report them to admin@redcarpetlife.in
Sponsored Content